Sort
130,381 grants matching “hiv”
Infections, immunity, and inflammation in cancer
$911,869Eric A Engels · Division Of Cancer Epidemiology And Genetics · ZIA · FY2011 · CA
Chemically Programmed Immunity
$911,805Carlos F Barbas · Scripps Research Institute, The · DP1 · FY2013 · CA
Facilitating the Implementation of Interim Methadone to Increase Treatment Access: A Multi-Site Implementation Trial
$911,747Robert P Schwartz · Friends Research Institute, Inc. · U01 · FY2020 · DA
Subingual-parenteral Vaccination to Prevent Oral HIV Transmission in Infants
$911,707Kristina Abel · Univ Of North Carolina Chapel Hill · R01 · FY2022 · DE
Improving HIV Service Delivery for People who Inject Drugs in Kazakhstan
$911,690Nabila El-Bassel · Columbia Univ New York Morningside · R01 · FY2019 · DA
Improving HIV Service Delivery for People who Inject Drugs in Kazakhstan
$911,690Nabila El-Bassel · Columbia Univ New York Morningside · R01 · FY2018 · DA
Immune Analytics Core (IAC)
$911,671Kristina Abel · Weill Medical Coll Of Cornell Univ · P01 · FY2025 · AI
A preclinical large animal model for globin gene transfer
$911,646John Tisdale · National Heart, Lung, And Blood Institute · ZIA · FY2010 · HL
Defining Drivers of HPV-associated Carcinogenesis
$911,640Paul F Lambert · University Of Wisconsin-Madison · R35 · FY2021 · CA
WSU COMMUNITY PROGRAMS FOR CLINICAL RESEARCH ON AIDS (CP
$911,624Wayne State University · U01 · FY2002 · AI
FOA# PS10-1085: HIV PREV. FOR MOST-AT-RISK (MARPS), REPUBLIC OF MOZAMBIQUE, UNDE
$911,621Martha Scherzer · Global Health Communications, Llc · U2G · FY2013 · PS
Establishing PREMISE: A PrEP Epidemiology, Modeling, and Surveillance System
$911,400Aaron Julius Siegler · Emory University · R01 · FY2024 · AI
Drug at the Right Place & Concentration: Optimizing Combination Vaginal Ring PrEP
$911,260Betsy C. Herold · Albert Einstein College Of Medicine, Inc · U19 · FY2017 · AI
Design and testing of germline-targeting and boosting immunogens to elicit 10E8-like broadly neutralizing antibodies against HIV
$911,231William R Schief · Scripps Research Institute, The · R01 · FY2020 · AI
Other Functions "SAMBA HIV Point of Care Nucleic Acid System for Resource Limited
$911,190Helen Lee · Diagnostics For The Real World, Ltd · N01 · FY2013 · AI
A geospatial analysis of hotspots and targeted injection settings pilot intervention for HIV prevention among people who inject drugs in Baltimore, Maryland
$911,181Carl A Latkin · Johns Hopkins University · R01 · FY2022 · DA
Factors Influencing the Health Behavior of Young African American Adults
$911,147Frederick X Gibbons · Dartmouth College · R01 · FY2008 · DA
Effect of opioid use disorder on HIV latent reservoirs and immune dysfunction assessed by single-cell transcriptomics
$911,136Christine Cheng · Boston University (Charles River Campus) · R33 · FY2021 · DA
Targeting PD-1 Pathway for Functional Cure of AIDS
$911,104Rama Rao Amara · Emory University · R37 · FY2019 · AI
Multiplexed Antigen-Specific Antibody Fc Profiling on a Chip for Point-of-Care Diagnosis of TB in HIV-infected Children
$911,002Bryan David Bryson · Massachusetts General Hospital · R01 · FY2024 · AI
HIV screening take-up: evaluating incentives and opt-out strategies
$910,993William Hatfield Dow · University Of California Berkeley · RC4 · FY2010 · AG
Investigation into the activation of multiple bnAb precursors using structure-designed immunogens and Ig knock-in mice
$910,966Daniel Kulp · Wistar Institute · R01 · FY2024 · AI
Capsule-intravaginal ring for sustained release of antibodies for non-hormonal contraception and vaginal protection against HIV
$910,955Keiichiro Kushiro · Mucommune, Llc · R44 · FY2021 · HD
Scaling up HPTN 074: a Cluster Randomized Implementation Trial of an Evidence-based Intervention for Antiretroviral Therapy for PWID in Vietnam
$910,907Vivian F. Go · Univ Of North Carolina Chapel Hill · R01 · FY2022 · DA
Advancing HIV Vaccine Development with a Lipid Nanodisc Platform
$910,905Kimmo Ilmari Rantalainen · Scripps Research Institute, The · R56 · FY2025 · AI